Healthcare Services Acquisition Multiples
Healthcare services trades at a structural premium to most operating sectors because of recurring patient revenue and the durability of payer relationships — but the multiple spread inside the sector is wide and driven by payer mix and reimbursement risk.
EBITDA Multiple Spread
Lower middle market, $2M–$50M EV
Median Multiple — 6 Year Trend
Annual median EBITDA multiple
Multiple by Deal Size Band
Median EBITDA multiple per EV band
Buyer Mix
Share of closed deals by buyer type
Sector thesis
Healthcare services is the most consolidation-active sector in lower middle market M&A. PE platforms — dental, dermatology, vet, behavioral health, ophthalmology — have driven multiple expansion in the larger bands, but the tailwind extends down to single-site $2–5M EV deals as add-ons.
The defining valuation question is reimbursement durability, not growth rate. A practice with 70% commercial payer mix and stable contracts will clear 1–2 turns higher than a comparable practice with heavy Medicaid exposure, even at identical EBITDA.
Current benchmarks
Median healthcare services EBITDA multiple is 7.8x in 2026, with the $15–35M EV band clearing 8.6x. Revenue multiples are less informative here than in SaaS because margin structure varies sharply by sub-specialty.
Diligence is the slowest in the lower middle market — 112 days on average — driven by credentialing verification, payer contract assignment, and regulatory review. Sellers who pre-build a credentialing data room shave 3–4 weeks off the timeline.
Frequently asked
What EBITDA multiple do healthcare service businesses sell for?
Lower middle market healthcare services traded at a median 7.8x EBITDA in 2026, with a range of 5.1x to 10.4x. PE platform deals at the top of the range can exceed 11x for multi-site assets with strong commercial payer mix.
Why does healthcare diligence take longer than other sectors?
Credentialing verification, payer contract assignment, regulatory review (Stark, Anti-Kickback, HIPAA), and CMS rate sensitivity each add weeks. Typical LOI-to-close is 112 days versus 78 for SaaS.
How does payer mix affect valuation?
Commercial payer concentration above 55% typically adds 1–2 turns of EBITDA versus a Medicaid-heavy comparable. Single-payer concentration above 35% is the most common reason a buyer reprices or walks.
Related sectors
Where does your business price?
Run the readiness diagnostic and get your sector-adjusted multiple range in 12 minutes.
Start diagnostic